Zymeworks ZYME
NASDAQ ZYME
$29.40 -0.50 (-1.66%)
As of: Sep 4, 2026 · 3:15 PM EDT

Zymeworks (ZYME) Other Working Capital Changes (2023 - 2026)

Zymeworks (ZYME) posted Other Working Capital Changes of -$340000.0 for Q1 2026, up 56.35% sequentially from -$779000.0 in Q4 2025, and up 83.76% YoY from -$185028.6 in Q1 2025.

Analysis

Zymeworks (ZYME) Other Working Capital Changes (2023 - 2026) Analysis & Trends

Zymeworks has reported Other Working Capital Changes for 4 years, with the latest figure at -$340000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes rose 83.76% year-over-year to -$340000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.4 million (down 1344.45% YoY) and the FY2025 annual result came in at -$23.2 million, down 751.76% from the prior year.
  • Other Working Capital Changes improved to -$340000.0 in Q1 2026 per ZYME's latest filing, from -$779000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $10.0 million in Q4 2024 and troughed at -$18.0 million in Q3 2023.
  • A 5-year average of -$544529.4 and a median of -$648000.0 in 2022 frame the typical range for Other Working Capital Changes.
  • The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes soared 121.76% in 2024, then tumbled 1046.35% in 2025.
  • Over 4 years, Other Working Capital Changes stood at $3.6 million in 2023, then plunged by 144.34% to -$1.6 million in 2024, then jumped by 51.28% to -$779000.0 in 2025, then jumped by 56.35% to -$340000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$340000.0, -$779000.0, and -$614000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Zymeworks 2.15 Bn 1.88 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -248,000.00
Jun 30, 2026 -248,000.00
Mar 31, 2026 -340,000.00
Mar 31, 2026 -340,000.00
Dec 31, 2025 -779,000.00
Dec 31, 2025 -779,000.00
Sep 30, 2025 -614,000.00
Sep 30, 2025 -614,000.00
Jun 30, 2025 -19.68 Mn
Jun 30, 2025 -19.68 Mn
Mar 31, 2025 -2.09 Mn
Mar 31, 2025 -2.09 Mn
Dec 31, 2024 -1.60 Mn
Dec 31, 2024 -1.60 Mn
Sep 30, 2024 3.33 Mn
Sep 30, 2024 3.33 Mn
Jun 30, 2024 2.08 Mn
Jun 30, 2024 2.08 Mn
Mar 31, 2024 -259,000.00
Mar 31, 2024 -259,000.00